Abstract:Background High post-surgical failure rates following tendon injury generate high medical costs and poor patient recovery. Cell-based tendon tissue engineering has the potential to produce fully functional replacement tissue and provide new strategies to restore tendon function and healing. In this endeavour, the application of mesenchymal stromal cells (MSCs) encapsulated in biomaterial scaffolds has shown great promise. However, a consensus on optimal promotion of tenogenic differentiation of MSCs has yet to be reached, although growth factors and mechanical cues are generally acknowledged as important factors. Methods In this study, we prepared a hydrogel cell culture system consisting of methacrylated poly( d , l -lactic acid-ethylene glycol- d ,l-lactic acid) (P(LA-EG-LA)) and gelatin methacrylate (GelMA) to encapsulate human bone marrow-derived MSCs (hBMSCs). We further systematically investigated the influence of static and intermittent cyclic uniaxial strain mechanical stimulation, in combination with transforming growth factor-β3 (TGF-β3) supplementation, on tenogenic differentiation of hBMSCs. Results Increased TGF-β3 concentration upregulated the tenogenic genes Scleraxis ( SCX) and collagen type I ( COL1A1) but showed no effects on tenascin-c ( TNC) and collagen type III ( COL3A1) expression. Mechanical stimulation had no observable effect on gene expression, but intermittent cyclic uniaxial strain stimulation improved matrix deposition. Together, these data provide new insights into how TGF-β3 and mechanical stimulation regulate MSC tenogenesis, with TGF-β3 promoting the expression of key tenogenic genes whilst mechanical stimulation aided matrix deposition in the engineered tissue. Furthermore, intermittent cyclic uniaxial strain at 3% elongation and 0.33 Hz for 1 h/day showed improved matrix effects compared to static strain. Conclusion Together, the most promising result for tenogenic differentiation of hBMSCs was identified as treatment with 5 ng/ml TGF-β3 under intermittent cyclic uniaxial strain (3% strain; 0.33 Hz; 1 h/day). This knowledge is of importance for the development of an improved protocol for tenogenic differentiation of MSCs and thereby for tendon tissue engineering. The translational potential of this article Tissue-engineered strategies for tendon repair require a consensus on the differentiation of mesenchymal stromal cells to tenocytes, which is currently lacking. This article provides a systematic investigation of two main tenogenic differentiation conditions to further development of a tenogenic differentiation protocol.

RhoA/Rho Kinase Signaling Regulates Transforming Growth Factor-Β1-induced Chondrogenesis and Actin Organization of Synovium-Derived Mesenchymal Stem Cells Through Interaction with the Smad Pathway

Rapamycin-Induced Autophagy Promotes the Chondrogenic Differentiation of Synovium-Derived Mesenchymal Stem Cells in the Temporomandibular Joint in Response to IL-1 β

Stromal Cell-Derived Factor-1Α and Transforming Growth Factor-Β1 Synergistically Facilitate Migration and Chondrogenesis of Synovium-Derived Stem Cells Through MAPK Pathways.

Rhoa/Rock, Cytoskeletal Dynamics, and Focal Adhesion Kinase Are Required for Mechanical Stretch-Induced Tenogenic Differentiation of Human Mesenchymal Stem Cells

A systematic investigation of the effects of TGF-β3 and mechanical stimulation on tenogenic differentiation of mesenchymal stromal cells in a poly(ethylene glycol)/gelatin-based hydrogel

Differential Smad2/3 linker phosphorylation is a crosstalk mechanism of Rho/ROCK and canonical TGF-β3 signaling in tenogenic differentiation

Cx43- and Smad-Mediated TGF-β/ BMP Signaling Pathway Promotes Cartilage Differentiation of Bone Marrow Mesenchymal Stem Cells and Inhibits Osteoblast Differentiation

Role of Integrin ß1 and Tenascin C Mediate TGF-SMAD2/3 Signaling in Chondrogenic Differentiation of BMSCs Induced by Type I Collagen Hydrogel

Transforming Growth Factor-Beta L Induces Type Ii Collagen And Aggrecan Expression Via Activation Of Extracellular Signal-Regulated Kinase 1/2 And Smad2/3 Signaling Pathways

SMAD3 and SMAD4 have a more dominant role than SMAD2 in TGFβ-induced chondrogenic differentiation of bone marrow-derived mesenchymal stem cells

RhoA, Rac1, and Cdc42 differentially regulate αSMA and collagen I expression in mesenchymal stem cells

Temporal Activation of Β-Catenin Signaling in the Chondrogenic Process of Mesenchymal Stem Cells Affects the Phenotype of the Cartilage Generated

Inhibition of TGF-β Signaling in Mesenchymal Stem Cells of Subchondral Bone Attenuates Osteoarthritis

Microtubule Stabilization Enhances the Chondrogenesis of Synovial Mesenchymal Stem Cells

Mek/Erk And P38 Mapk Regulate Chondrogenesis Of Rat Bone Marrow Mesenchymal Stem Cells Through Delicate Interaction With Tgf-Beta 1/Smads Pathway

Scaffolds containing GAG-mimetic cellulose sulfate promote TGF-β interaction and MSC Chondrogenesis over native GAGs

Involvement of Rho-associated Coiled-Coil Kinase Signaling Inhibition in TGF-β1/Smad2, 3 Signal Transduction in Vitro

Strontium Ranelate Promotes Chondrogenesis Through Inhibition of the Wnt/β-catenin Pathway

Co-overexpression of TGF-β and SOX9 Via Raav Gene Transfer Modulates the Metabolic and Chondrogenic Activities of Human Bone Marrow-Derived Mesenchymal Stem Cells.

Cross-talk Between TGF-beta/SMAD and Integrin Signaling Pathways in Regulating Hypertrophy of Mesenchymal Stem Cell Chondrogenesis under Deferral Dynamic Compression.

Expression of Transforming Growth Factor Β1 in Mesenchymal Stem Cells: Potential Utility in Molecular Tissue Engineering for Osteochondral Repair